Analyze Diet
Experimental cell research2026; 459(1); 115000; doi: 10.1016/j.yexcr.2026.115000

Serum-free medium modulates the immunomodulatory and anabolic function of equine bone marrow-derived mesenchymal stromal cells.

Abstract: Adult bone marrow-derived mesenchymal stromal cells (BM-MSCs) hold significant therapeutic potential in human and veterinary medicine. Traditionally, BM-MSC cultures use fetal bovine serum (FBS) to promote growth, but this practice introduces batch variability and xenogeneic contamination that complicate clinical translation. While serum-free medium (SFM) alternatives have been optimized for human MSCs, limited options have been explored for alternative or veterinary species. Here, we compared a chemically defined, customizable SFM formulation with conventional serum-containing medium (SCM) for isolation and expansion of equine bone marrow mesenchymal cells (eqBM-MSCs). Both conditions supported adherence and trilineage differentiation. However, SFM cultures maintained a colony-based growth pattern across passages and showed up to 3-fold higher colony-forming output. SFM cells were enriched for a CD29 population relative to SCM, despite slower proliferation. At early passage, SFM cells displayed a two-fold longer population doubling time than SCM with reduced cumulative expansion across serial passaging. Quantitative proteomics indicated that SFM expansion was associated with increased abundance of proteins mapping to immune signaling and repair-related pathways, including neutrophil degranulation, interferon-associated signaling, and hemostasis/angiogenesis, whereas SCM was enriched for pathways linked to proliferation and metabolism. Cytokine profiling further showed elevated KC-GRO, IL-8, and FGF in SFM relative to SCM. Together, these findings demonstrate the potential of a defined SFM platform to modulate eqBM-MSC growth behavior and protein/cytokine signatures, while highlighting a scalability trade-off between yield and phenotype that will require further optimization and functional validation.
Publication Date: 2026-03-25 PubMed ID: 41895434DOI: 10.1016/j.yexcr.2026.115000Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigates how using a chemically defined serum-free medium (SFM) versus traditional serum-containing medium (SCM) affects the growth, characteristics, and function of equine bone marrow-derived mesenchymal stromal cells (eqBM-MSCs).
  • It finds that SFM influences cellular phenotype and protein expression related to immune and repair functions but may reduce expansion potential compared to SCM.

Background and Purpose

  • Adult bone marrow-derived mesenchymal stromal cells (BM-MSCs) are important for therapies in humans and animals due to their regenerative and immunomodulatory properties.
  • Typically, culture media for BM-MSCs contain fetal bovine serum (FBS), which helps cell growth but presents risks such as batch variability and contamination from non-species sources (xenogeneic contamination).
  • Serum-free media (SFM) offers a defined and potentially safer alternative, already optimized for human MSCs, but less is known about their effects on veterinary species like horses.
  • The research aims to compare eqBM-MSC isolation and growth in SFM versus traditional serum-containing medium (SCM), focusing on cellular behavior and functional protein expression.

Methodology

  • A chemically defined, customizable serum-free medium was tested alongside conventional serum-containing medium for the culture of equine BM-MSCs.
  • Both media were assessed for their ability to support:
    • Cell adherence to culture plates
    • Trilineage differentiation potential (ability to become bone, cartilage, and fat cells)
    • Colony-forming unit (CFU) output as a growth measure
    • Surface marker expression specific to MSCs (e.g., CD29)
    • Cell proliferation rates
  • Quantitative proteomic analysis was conducted to identify differences in protein abundance and pathways enriched in cells grown in each medium.
  • Cytokine profiling measured levels of key secreted molecules linked to immune function and tissue repair.

Key Findings

  • Growth and morphology:
    • Both SFM and SCM allowed cells to adhere and differentiate into multiple lineages.
    • SFM cultures displayed colony-based growth and produced up to three times more colonies than SCM.
    • Cells grown in SFM showed slower proliferation with roughly double the population doubling time compared to SCM.
    • This slower growth led to reduced total expansion across passages in SFM.
    • SFM cells were enriched for the CD29 surface marker, a characteristic MSC marker, suggesting possible phenotypic differences.
  • Proteomic and pathway differences:
    • SFM-grown cells showed increased abundance of proteins involved in immune signaling and tissue repair mechanisms such as:
      • Neutrophil degranulation
      • Interferon-associated signaling
      • Hemostasis and angiogenesis pathways
    • SCM-grown cells had higher levels of proteins linked to cell proliferation and metabolic processes.
  • Cytokine secretion:
    • SFM cultures secreted higher levels of inflammatory and growth-related cytokines, including KC-GRO, IL-8, and fibroblast growth factor (FGF).

Implications and Conclusions

  • The serum-free medium can significantly modulate the phenotype and secretory profile of equine BM-MSCs, potentially enhancing their immunomodulatory and repair-related functions.
  • There is a trade-off with SFM between maintaining a desirable MSC phenotype and the overall cell expansion yield due to slower proliferation.
  • These findings highlight the importance of further optimizing serum-free culture conditions to increase scalability while preserving beneficial cell functions, which is crucial for veterinary therapeutic applications.
  • Future work is needed to confirm how these in vitro differences affect MSC function in vivo and therapeutic efficacy.

Cite This Article

APA
Tehrani AH, Toth K, Osinchuk N, Dufour A, Krawetz R, Sen A, Sparks H. (2026). Serum-free medium modulates the immunomodulatory and anabolic function of equine bone marrow-derived mesenchymal stromal cells. Exp Cell Res, 459(1), 115000. https://doi.org/10.1016/j.yexcr.2026.115000

Publication

ISSN: 1090-2422
NlmUniqueID: 0373226
Country: United States
Language: English
Volume: 459
Issue: 1
Pages: 115000
PII: S0014-4827(26)00117-5

Researcher Affiliations

Tehrani, Ashkan H
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada; McCaig Institute for Bone and Joint Health, Calgary, Alberta, Canada; Pharmaceutical Production Research Facility, University of Calgary, Calgary, Alberta, Canada; Morphovis Biotech Inc., Calgary, Alberta, Canada.
Toth, Kasara
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada; McCaig Institute for Bone and Joint Health, Calgary, Alberta, Canada.
Osinchuk, Nicole
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada; McCaig Institute for Bone and Joint Health, Calgary, Alberta, Canada.
Dufour, Antoine
  • McCaig Institute for Bone and Joint Health, Calgary, Alberta, Canada; Department of Biochemistry and Molecular Biology, Cummings School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Krawetz, Roman
  • McCaig Institute for Bone and Joint Health, Calgary, Alberta, Canada; Department of Cell Biology & Anatomy, Cummings School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Surgery, Cummings School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Sen, Arindom
  • McCaig Institute for Bone and Joint Health, Calgary, Alberta, Canada; Pharmaceutical Production Research Facility, University of Calgary, Calgary, Alberta, Canada; Department of Chemical and Petroleum Engineering, Schulich School of Engineering, University of Calgary, Calgary, Alberta, Canada.
Sparks, Holly
  • Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada; McCaig Institute for Bone and Joint Health, Calgary, Alberta, Canada. Electronic address: Holly.Sparks@ucalgary.ca.

MeSH Terms

  • Animals
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / drug effects
  • Mesenchymal Stem Cells / immunology
  • Mesenchymal Stem Cells / metabolism
  • Horses
  • Cell Differentiation / drug effects
  • Culture Media, Serum-Free / pharmacology
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / drug effects
  • Bone Marrow Cells / metabolism
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Cell Culture Techniques / methods
  • Immunomodulation / drug effects

Conflict of Interest Statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Citations

This article has been cited 0 times.